Inflammatory Markers in Patients With Active Migraine Headaches

Completed

Conditions studied: Migraine

In brief

The purpose of this study is to determine whether C-Reactive Protein (CRP) is elevated in patients with active migraine headaches. Secondary goal is to determine whether other inflammatory markers, such as Calcitonin Gene Peptide (CGRP), Vasoactive Intestinal Polypeptide (VIP) or Substance P (SP) are elevated in patients having a migraine headache.

Key facts

Study ID

NCT00471861

Run by

Westside Family Medical Center, P.C.

People needed

30

Starts

2007-05-01

Expected to finish

2009-02-01

Last updated by the study team

2011-08-08

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects must sign a written informed consent.
• Enrollment population would include males and females 21 years of age to 65 years of age.
• Non-migraine subjects will be allowed in the control group
• Have episodic migraine headaches
• Patients to satisfy the diagnosis of migraine headaches with aura, without aura or mixed.
• Must be able to differentiate migraine headaches from other headaches

You may not qualify if…

• Any medical condition in the opinion of the investigator that would make the subject unsuitable for enrollment.
• Basilar or hemiplegic migraine headaches.
• Pregnant woman or a nursing mother
• History (within 1 year) or current evidence of drug or alcohol abuse.
• More than 15 migraine headaches per month
• Chronic daily headaches
• Chronic use of NSAIDs
• Current participation in a research study or within the last 30 days.

Where it is running

• Westside Family Medical Center, P.C. — Kalamazoo, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.